Concepedia

Tim H. M. Jonckers

TH

Statistics

Publications

34

Citations

1.9K

H-Index

23

Active since

1999

Affiliations

Janssen (Belgium)(Current)

University of Antwerp

Janssen (United States)

Janssen (France)

Medivir (Sweden)

Tim H. M. Jonckers is an author at Janssen (Belgium) specializing in antiviral pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1999–2024

34

Publications

34

Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor

Dominique Surleraux, Abdellah Tahri, Wim G. Verschueren et al. · Journal of Medicinal Chemistry · 2004 · 256 citations

, , +17

A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction

Suzanne J. F. Kaptein, Olivia Goethals, Dominik Kiemel et al. · Nature · 2021 · 192 citations · Full text

, , +13

Molecular mechanism of respiratory syncytial virus fusion inhibitors

Michael B. Battles, Johannes P. M. Langedijk, Polina Furmanova-Hollenstein et al. · Nature Chemical Biology · 2015 · 171 citations · Full text

, , +14

Synthesis, Cytotoxicity, and Antiplasmodial and Antitrypanosomal Activity of New Neocryptolepine Derivatives

Tim H. M. Jonckers, Sabine Van Miert, K. Cimanga et al. · Journal of Medicinal Chemistry · 2002 · 151 citations

, , +16

A small-molecule fusion inhibitor of influenza virus is orally active in mice

Maria J. P. van Dongen, Rameshwar U. Kadam, Jarek Juraszek et al. · Science · 2019 · 146 citations

, , +17

1–5 of 34